Trial reportFrontiers in sports and active living2026
Effects of single-dose methylphenidate on motor performance in physically active college students with attention-deficit/hyperactivity disorder: a randomized crossover trial.
Trial report in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methylphenidate (MPH) is commonly used for managing core symptoms of attention-deficit hyperactivity disorder (ADHD). However, its effects on motor performance in active individuals with ADHD have been scarcely documented. This study aimed to assess the acute effects of a single dose of MPH on agility, balance, and physiological parameters at rest and after motor tests, in physically active participants with ADHD. For this randomized crossover study, we recruited 35 physical education college students with ADHD (mean age 25.3 years; 65.7% males). Participants used their prescribed MPH medication. The following evaluations were performed both before and after MPH treatment: motor performance tests (a zigzag agility test, both with and without leading a ball; and a balance test), physiological measurements (heart rate, blood pressure, core temperature) recorded at rest and after the motor tests (at least one week apart); mental evaluations using a rated perceived exertion (RPE) scale. We found no significant differences in motor performance, physiological measures, or RPE with vs. without MPH. These results suggest that while MPH may enhance certain motor functions as shown in other studies, such effects are not universally beneficial across all motor performance measures in young physically active adults diagnosed with ADHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.